Contraception logo Elsevier logo

Publisher: Elsevier

Related content
Volume 56, Number 3, September 1997

< previous issue | all issues | next issue >

The Use of Oral Contraceptives and the Occurrence of Acute Myocardial Infarction in Young Women - Results From the Transnational Study on Oral Contraceptives and the Health of Young Women
pp. 129-140(12)
Authors: Transnational Research Group; Lewis M.A.; Heinemann L.A.J.; Spitzer W.O.; MacRae K.D.; Bruppacher R.

First-Time Use of Newer Oral Contraceptives and the Risk of Venous Thromboembolism
pp. 141-146(6)
Authors: Suissa S.; Blais L.; Spitzer W.O.; Cusson J.; Lewis M.; Heinemann L.

The Cardiovascular Safety of Triphasic Contraceptive Steroids
pp. 157-163(7)
Authors: Shaarawy M.; Nafea S.; Abdel-Aziz O.; Rahseed K.; Sheiba M.

Misoprostol 3, 4, or 5 Days After Methotrexate for Early Abortion - A Randomized Trial
pp. 169-174(6)
Authors: Esteve J.L.C.I.; Velazco A.; Varela L.; Cabezas E.; Fernandez C.; Sanchez C.

Modulation of Ovarian Function by an Oral Contraceptive Containing 30 mug Ethinyl Estradiol in Combination With 2.00 mg Dienogest
pp. 185-191(7)
Authors: Spona J.; Feichtinger W.; Kindermann C.; Moore C.; Mellinger U.; Walter F.; Graser T.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page